Suppr超能文献

来自人类U6和2型腺病毒VAI启动子的RNA聚合酶III转录对人类TFIIIB的一个亚基——人类BRF有不同的需求。

RNA polymerase III transcription from the human U6 and adenovirus type 2 VAI promoters has different requirements for human BRF, a subunit of human TFIIIB.

作者信息

Mital R, Kobayashi R, Hernandez N

机构信息

Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.

出版信息

Mol Cell Biol. 1996 Dec;16(12):7031-42. doi: 10.1128/MCB.16.12.7031.

Abstract

Mammalian TFIIIB can be separated into two fractions required for transcription of the adenovirus type 2 VAI gene, which have been designated 0.38M-TFIIIB and 0.48M-TFIIIB. While 0.48M-TFIIIB has not been characterized, 0.38M-TFIIIB corresponds to a TBP-containing complex. We describe here the purification of this complex, which consists of TBP and a closely associated polypeptide of 88 kDa, and the isolation of a cDNA corresponding to the 88-kDa polypeptide. The predicted protein sequence reveals that the 88-kDa polypeptide corresponds to a human homolog of the Saccharomyces cerevisiae BRF protein, a subunit of yeast TFIIIB. Human BRF (hBRF) probably corresponds to TFIIIB90, a protein previously cloned by Wang and Roeder (Proc. Natl. Acad. Sci. USA 92:7026-7030, 1995), although its predicted amino acid sequence differs from that reported for TFIIIB90 over a stretch of 67 amino acids as a result of frameshifts. Immunodepletion of more than 90 to 95% of the hBRF present in a transcription extract severely debilitates transcription from the tRNA-type VAI promoter but does not affect transcription from the TATA box-containing human U6 promoter, suggesting that the 0.38M-TFIIIB complex, and perhaps hBRF as well, is not required for U6 transcription.

摘要

哺乳动物TFIIIB可分为腺病毒2型VAI基因转录所需的两个组分,分别命名为0.38M-TFIIIB和0.48M-TFIIIB。虽然0.48M-TFIIIB尚未得到鉴定,但0.38M-TFIIIB对应于一个含TBP的复合物。我们在此描述了该复合物的纯化过程,它由TBP和一个紧密相关的88 kDa多肽组成,并分离出了与该88 kDa多肽对应的cDNA。预测的蛋白质序列显示,该88 kDa多肽对应于酿酒酵母BRF蛋白的人类同源物,后者是酵母TFIIIB的一个亚基。人BRF(hBRF)可能对应于TFIIIB90,这是一种先前由Wang和Roeder克隆的蛋白(美国国家科学院院刊92:7026 - 7030, 1995),尽管由于移码,其预测的氨基酸序列在一段67个氨基酸的区域与报道的TFIIIB90不同。转录提取物中超过90%至95%的hBRF被免疫去除后,tRNA型VAI启动子的转录严重受损,但不影响含TATA盒的人U6启动子的转录,这表明0.38M-TFIIIB复合物,可能还有hBRF,对于U6转录不是必需的。

相似文献

引用本文的文献

1
RNA Polymerase III Subunit Mutations in Genetic Diseases.遗传性疾病中的RNA聚合酶III亚基突变
Front Mol Biosci. 2021 Jul 30;8:696438. doi: 10.3389/fmolb.2021.696438. eCollection 2021.
3
Suppressive Effects of EGCG on Cervical Cancer.EGCG 对宫颈癌的抑制作用。
Molecules. 2018 Sep 12;23(9):2334. doi: 10.3390/molecules23092334.
6
RNA polymerase III repression by the retinoblastoma tumor suppressor protein.视网膜母细胞瘤肿瘤抑制蛋白对RNA聚合酶III的抑制作用
Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):385-92. doi: 10.1016/j.bbagrm.2012.09.011. Epub 2012 Oct 12.

本文引用的文献

9
Architecture of a yeast U6 RNA gene promoter.酵母U6 RNA基因启动子的结构
Mol Cell Biol. 1993 May;13(5):3015-26. doi: 10.1128/mcb.13.5.3015-3026.1993.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验